| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |